Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination-Reference-Cited by-同舟云学术

Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination

Published:2014-02-27 Issue:5 Volume:10 Page:1155-1165
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Romanowski Barbara,Schwarz Tino F,Ferguson Linda M,Ferguson Murdo,Peters Klaus,Dionne Marc,Schulze Karin,Ramjattan Brian,Hillemanns Peter,Behre Ulrich,Suryakiran Pemmaraju,Thomas Florence,Struyf Frank

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.28022

Reference33 articles.

1. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

2. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

3. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

4. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years

5. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different dose series of human papillomavirus vaccine in young females: a pair-wise meta-analysis and network meta-analysis from randomized controlled trials;Frontiers in Public Health;2023-09-21

2. HPV16/18 Antibody Responses After a Single Dose of Nonavalent HPV Vaccine;Pediatrics;2023-06-15

3. Human Papillomavirus Vaccines;Plotkin's Vaccines;2023

4. Immunogenicity and safety of a bivalent, adjuvant system 04–adjuvanted human papillomavirus vaccine in healthy female volunteers aged 15–25: a randomized, double-blind, phase III, noninferiority clinical trial;European Journal of Cancer Prevention;2022-03-29

5. Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution;Vaccines;2022-01-13